[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ruseva et al., 2009 - Google Patents

Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation

Ruseva et al., 2009

Document ID
1631690438329937336
Author
Ruseva Z
Geiger P
Hutzler P
Kotzsch M
Luber B
Schmitt M
Gross E
Reuning U
Publication year
Publication venue
Experimental cell research

External Links

Snippet

The tetraspanin KAI1 had been described as a metastasis suppressor in many different cancer types, a function for which associations of KAI1 with adhesion and signaling receptors of the integrin superfamily likely play a role. In ovarian cancer, integrin αvβ3 …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Ruseva et al. Tumor suppressor KAI1 affects integrin αvβ3-mediated ovarian cancer cell adhesion, motility, and proliferation
Tchaicha et al. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin
Xiong et al. Integrins regulate stemness in solid tumor: an emerging therapeutic target
Wei et al. Urokinase receptors promote β1 integrin function through interactions with integrin α3β1
Salvucci et al. EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures
Liu et al. KAI1/CD82, a tumor metastasis suppressor
Simonavicius et al. Pericytes promote selective vessel regression to regulate vascular patterning
JP5965322B2 (en) Inhibition of AXL signaling in antimetastatic therapy
Colorado et al. Anti-angiogenic cues from vascular basement membrane collagen
Weis et al. Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
JP2021080301A (en) Cancer treatment agent
Ishikawa et al. Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146)
Johnston et al. Osteopontin as a target for cancer therapy
Guijarro-Munoz et al. The axonal repellent Slit2 inhibits pericyte migration: potential implications in angiogenesis
Sun et al. A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro
Zeng et al. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis
Agrez et al. Multiplicity of fibronectin-binding αv integrin receptors in colorectal cancer
Nam et al. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of βig-h3, via αvβ3 integrin
Ma et al. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells
Upheber et al. Alternative splicing of KAI1 abrogates its tumor-suppressive effects on integrin αvβ3-mediated ovarian cancer biology
WO2009061448A2 (en) Methods and compositions for the treatment of proteinuric diseases
Ziober et al. Expression of the α7β1 laminin receptor suppresses melanoma growth and metastatic potential
Larrucea et al. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells
Tucker et al. Lipoprotein receptor–related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells
Carriero et al. Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis